Am. J. Respir. Crit. Care Med., Volume 162, Number 4, October 2000, 1235-1238

Deletion Polymorphisms in the Angiotensin Converting Enzyme Gene Are Associated with Pulmonary Hypertension Evoked by Exercise Challenge in Patients with Chronic Obstructive Pulmonary Disease

HIROSHI KANAZAWA, TAKASHI OKAMOTO, KAZUTO HIRATA, and JUNICHI YOSHIKAWA

First Department of Internal Medicine, Osaka City University Medical School, Osaka, Japan

Angiotensin converting enzyme (ACE) plays an important role in the pathogenesis of pulmonary hypertension. In this study we determined whether the deletion (D)/insertion (I) polymorphism in the ACE gene may be associated with pulmonary hypertension evoked by exercise challenge in patients with chronic obstructive pulmonary disease (COPD). ACE genotypes were determined in 19 patients with COPD. All patients underwent right heart catheterization followed by a constant-load exercise test while breathing room air or oxygen. Subgroups were created of seven patients with the II genotype, six with the ID genotype, and six with the DD genotype who were well-matched with respect to age, blood gas data at rest or after exercise, baseline lung function, results of incremental exercise testing, and hemodynamic data at rest. The mean pulmonary arterial pressure () and pulmonary vascular resistance (Rpv) at rest in the three subgrpoups did not differ significantly during breathing of either room air or oxygen. However, the after exercise challenge in patients with the DD genotype (55.7 ± 4.9 mm Hg [mean ± SD]) was significantly higher than in patients with the II genotype (42.6 ± 7.1 mm Hg, p = 0.008). The Rpv after exercise in patients with the DD genotype was also significantly higher than in patients with the ID and II genotypes. During breathing of oxygen to diminish acute hypoxic pulmonary vasoconstriction, the in patients with the DD genotype (52.3 ± 3.1 mm Hg) was higher than in patients with the ID genotype (40.5 ± 5.9 mm Hg, p = 0.0049) or the II genotype (37.7 ± 5.9 mm Hg, p = 0.0027). In addition, the Rpv in patients with the DD genotype was higher than in patients with the ID and II genotypes. These results suggest that D-I polymorphism in the ACE gene may be associated with pulmonary hypertension evoked by exercise challenge in patients with COPD. However, the number of patients in this study was very small for a genetic association study, and our results should be examined in larger studies.

This article has been cited by other articles:

				Z. Ammous, N. R. Hackett, M. W. Butler, T. Raman, I. Dolgalev, T. P. O'Connor, B.-G. Harvey, and R. G. Crystal Variability in Small Airway Epithelial Gene Expression Among Normal Smokers Chest, June 1, 2008; 133(6): 1344 - 1353. [Abstract] [Full Text] [PDF]

				L. Mascitelli, F. Pezzetta, R. Tkacova, and P. Joppa Inhibition of the Renin-Angiotensin System in Patients With COPD and Pulmonary Hypertension Chest, March 1, 2007; 131(3): 938 - 939. [Full Text] [PDF]

				M. Meysman Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial. Eur. Respir. J., September 1, 2006; 28(3): 670 - 670. [Full Text] [PDF]

				S. Andreas From the authors Eur. Respir. J., September 1, 2006; 28(3): 670 - 671. [Full Text] [PDF]

				J. Hotta, M. Hanaoka, Y. Droma, Y. Katsuyama, M. Ota, and T. Kobayashi Polymorphisms of Renin-Angiotensin System Genes With High-Altitude Pulmonary Edema in Japanese Subjects Chest, September 1, 2004; 126(3): 825 - 830. [Abstract] [Full Text] [PDF]

				S. Patel, D.R. Woods, N.J. Macleod, A. Brown, K.R. Patel, H.E. Montgomery, and A.J. Peacock Angiotensin-converting enzyme genotype and the ventilatory responseto exertional hypoxia Eur. Respir. J., November 1, 2003; 22(5): 755 - 760. [Abstract] [Full Text] [PDF]

				R Forth and H Montgomery ACE in COPD: a therapeutic target? Thorax, July 1, 2003; 58(7): 556 - 558. [Full Text]

				H Kanazawa, K Hirata, and J Yoshikawa Effects of captopril administration on pulmonary haemodynamics and tissue oxygenation during exercise in ACE gene subtypes in patients with COPD: a preliminary study Thorax, July 1, 2003; 58(7): 629 - 631. [Abstract] [Full Text] [PDF]

				D. R. Woods, A. J. Pollard, D. J. Collier, Y. Jamshidi, V. Vassiliou, E. Hawe, S. E. Humphries, and H. E. Montgomery Insertion/Deletion Polymorphism of the Angiotensin I-Converting Enzyme Gene and Arterial Oxygen Saturation at High Altitude Am. J. Respir. Crit. Care Med., August 1, 2002; 166(3): 362 - 366. [Abstract] [Full Text] [PDF]

				H. Kanazawa, T. Otsuka, K. Hirata, and J. Yoshikawa Association Between the Angiotensin-Converting Enzyme Gene Polymorphisms and Tissue Oxygenation During Exercise in Patients With COPD Chest, March 1, 2002; 121(3): 697 - 701. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1789 - 1804. [Full Text] [PDF]